No more chemotherapy for certain cancer! - healthprevention.ch
 
Geneva:
+4122 840 33 34
 
Moscow:
+7(903)720 80 57

No more chemotherapy for certain cancer!

Date: 04/07/2018
Last edited: 04/07/2018

This is a breakthrough: many patients with breast or lung cancer can avoid chemotherapy and its serious side effects, according to studies  that should change the way cancers are treated.

The first good news is for women who have had breast cancer. Up to 70% of them can avoid chemotherapy, depending on the results of an existing genetic test, and be treated with hormonal drugs usually prescribed after an operation to remove the tumor.

Tumor analyzed genetically

As for lung cancer, studies also presented at the big annual cancer conference in Chicago (ASCO) show a new era where patients will see their tumors analyzed genetically. If certain mutations are detected, a tumor-specific drug may be prescribed.

Otherwise, in most cases, the patient will be able to receive a new type of treatment, such as immunotherapy. The majority of patients would therefore avoid nausea, hair loss and other side effects caused by highly toxic chemotherapy.

Thanks to a succession of clinical trials, the entire lung cancer treatment model has been turned upside down, an “extraordinary” change, according to a specialist.

Breast cancer

Currently, many women undergo chemotherapy after the surgical removal of the tumor, in addition to hormone therapy drugs, to prevent the eventual return of cancer.

But an international study on 10,000 women concluded that the level justifying the use of chemotherapy could be revised safely. For years, a genetic test performed on the tumor has predicted the probability of recurrence. This test gives a score between 0 and 100. Until now, chemotherapy was recommended above 25. Below 10, it was not. This posed a dilemma for women in the gray zone, between 11 and 25.

The study showed that for these women, after nine years of follow-up, chemotherapy did not bring anything.

Lung cancer

For the most common type of lung cancer, it is immunotherapy that offers huge hope. Pharmaceutical companies are competing fiercely in this field.

At the conference, a study on the Keytruda, or pembrolizumab made big noise. The American company Merck, known as MSD abroad, has bet everything on it. It is taken intravenously, every three weeks, and has become the best-seller of the laboratory, especially against melanoma and lung cancer.

Immunotherapy drugs help the patient’s immune system do what it is supposed to do: detect and attack the tumor. The method does not work against all types of cancers and can cause serious side effects, sometimes to the point where patients stop treatment.

For the latest clinical trial, funded by MSD, the researchers compared the efficacy of taking Keytruda alone to chemotherapy (the effect of the combination of the two protocols was studied separately, and shows good results in some cases) . Patients first treated with pembrolizumab lived four to eight months longer than those who received only chemotherapy. Above all, they were less likely to suffer serious side effects (18% versus 41%).

 

Comments
Articles
Patient registration form
Topics
Examination Incorpore
age management
Anti-aging
prevention
weight management
detoxification
weight loss
nutrition
oncology
cancer
allergy
dermatology
skin
oncology treatment
diagnosis
cardiology
heavy metal
immunology
check-up
Fertility
cosmetology
skincare
stem cells
Genetics
Blood pressure
DNA
gynecology
pain
liver detox
heart MRI
Examination partner centres
infertility
Allergology
chelation
covid19
liver
urology
Allergology treatment
gastroenterology
Sleep
tinnitus
probiotics
pregnancy
joints
radiology
headache
Hepatitis C
Apnea
NAD+
obstetrics
mesotherapy
rehabilitation
arsenic
candida
andropause
immune system
neurology
breast cancer
immunotherapy
research
PRP
menopause
rhesus factor
pancreas
knee
oncoloy
propofole
magnesium
hand
cellulite
nephrology
R-loops
abdominal pain
migraine
reconstruction
erectile dysfunction
diet
Omega-3
hormones
hip
shoulder
telomere
obstertics
blood test
general surgery
back pain
colonoscopy
mercury
flu
mastectomy
regeneration
water
Treatment programs
kidney
proctology
cellmen
reflexology
hyaluronic acid
acnea
oral checkup
pomegranate
cellcosmet
sexuality
gastroscopy
migraines
dermatitis
liquid biopsy
rheumatology
vitamin K
anti-aging
gastritis
chronic headaches
orthopedics
food
preventiion
ulcer
endocrinology
Дерматология
vitamin b12
herniated disc
endometriosis
digestion
stress
intestinal flora
beauty
brain surgery awake
acne
ophthalmology
depression
exercise
beau-rivage
nutrigenomics
psoriasis
narcosis
LED therapy
flu vaccine
plastic surgery
iron
sports
excimer laser
lungs
food intolerances
second opinion
cholesterol
light therapy
biopsy
pneumology
mammography
diabetes
sugar